LWM
SGMO

LJI Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

LJI Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,460
Closed -$4.8K – 209
2026
Q1 		$4.8K Hold
19,460
– – ﹤0.01% 194
2025
Q4 		$8.17K Hold
19,460
– – ﹤0.01% 190
2025
Q3 		$13.1K Sell
19,460
-300
-2% -$162 ﹤0.01% 185
2025
Q2 		$10.7K Sell
19,760
-4,000
-17% -$2.38K ﹤0.01% 186
2025
Q1 		$15.6K Sell
23,760
-500
-2% -$529 ﹤0.01% 182
2024
Q4 		$24.7K Sell
24,260
-1,800
-7% -$3.29K ﹤0.01% 180
2024
Q3 		$22.6K Sell
26,060
-10,100
-28% -$7.4K ﹤0.01% 191
2024
Q2 		$13K Sell
36,160
-4,100
-10% -$2.21K ﹤0.01% 185
2024
Q1 		$27K Sell
40,260
-3,900
-9% -$2.83K 0.01% 151
2023
Q4 		$24K Buy
44,160
+1,600
+4% +$738 0.01% 169
2023
Q3 		$25.5K Sell
42,560
-7,550
-15% -$8.08K 0.01% 161
2023
Q2 		$65.1K Buy
50,110
+11,000
+28% +$15K 0.02% 171
2023
Q1 		$68.8K Sell
39,110
-12,500
-24% -$35.7K 0.02% 156
2022
Q4 		$162K Buy
+51,610
New +$200K 0.06% 141

Other funds holding SGMO

AIM
Axiom Investment Management New York $150M AUM
HIG
Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

LJI Wealth Management's SGMO Position: Q2 2026 in Review

LJI Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 19,460 shares — an estimated $4.8K sold.

LJI Wealth Management first reported a position in SGMO in Q4 2022 and held it in 14 quarters. The position peaked at $162K in Q4 2022. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

  • LJI Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
  • LJI Wealth Management sold 19,460 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $4.8K.
  • LJI Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2022 and held it in 14 quarters.
  • LJI Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $162K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on LJI Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.